GEIGER COUNTER LIMITED
GCL | IL
Overview
Corporate Details
- ISIN(s):
- GB00B15FW330 (+1 more)
- LEI:
- 549300O6PWGLLYV1QX57
- Country:
- Jersey
- Address:
- Ordnance House, JE4 8PW St Helier
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Genedrive PLC develops and commercializes easy-to-use, point-of-care pharmacogenetic tests for improved clinical outcomes. Our tests, such as the CYP2C19 ID Kit and MT-RNR1 ID Kit, are designed for rapid, time-critical settings.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-13 15:36 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-13 11:43 |
Transaction in Own Shares
Share Buyback
|
English | 10.5 KB | |
| 2025-08-12 16:23 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-12 09:50 |
Transaction in Own Shares
Share Buyback
|
English | 10.6 KB | |
| 2025-08-11 10:30 |
Transaction in Own Shares
Share Buyback
|
English | 10.6 KB | |
| 2025-08-08 18:10 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-08 08:00 |
Post-Annual General Meeting Information
Results of General Meeting
|
English | 15.4 KB | |
| 2025-08-07 16:04 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-07 10:58 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 9.2 KB | |
| 2025-08-07 10:54 |
Transaction in Own Shares
Share Buyback
|
English | 10.5 KB | |
| 2025-08-05 16:13 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-04 18:08 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-01 18:21 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-01 12:52 |
Transaction in Own Shares
Share Buyback
|
English | 10.4 KB | |
| 2025-07-31 15:35 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
CHOSA Oncology AB | Sweden | CHOSA | |
|
Cinclus Pharma Holding AB | Sweden | CINPHA | |
|
Circio Holding ASA | Norway | CRNA | |
|
CIZZLE BIOTECHNOLOGY HOLDINGS PLC | United Kingdom | CIZ | |
|
CLAL Biotechnology Industries Ltd. | Israel | CBI | |
|
Combigene AB | Sweden | COMBI | |
|
Compugen Ltd. | Israel | CGEN | |
|
Corline Biomedical AB | Sweden | CLBIO | |
| CRISM Therapeutics Corporation | Virgin Islands (British) | N/A | ||
|
Curasight A/S | Denmark | CURAS |